Friday, 1 July, 2022
TopicPharma sector

Topic: Pharma sector

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

To boost pharma investments, Modi govt sets up panel to revamp policies & draw up action plan

The expert panel, consisting of 5 members from the industry and a govt official, has highlighted archaic labour laws & flawed definitions of fast-tracking mechanisms as hiccups. 

Govt repeats warning to pharma firms, says don’t ‘promote products in unethical ways’

In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.

Govt looks to boost domestic production of raw ingredients for medicines, revises guidelines

The govt has changed certain criteria under its Production-Linked Incentive scheme that was approved in March to reduce dependence on China.

Test efficacy of umifenovir alone as Covid drug, not with favipiravir — govt panel to Macleods

Mumbai-based Macleods Pharmaceuticals had sought permission to conduct clinical trials on umifenovir, a Russian drug used to treat influenza.

Modi govt to form standing committee to prevent drugmakers from evading price control

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Himachal drug firm under scanner again after cough syrup causes ‘kidney failure’ in 2-yr-old

Himachal-based Digital Vision was earlier booked by state govt in February for selling another contaminated syrup, which led to 9 infant deaths in J&K and one in Haryana.

Depending on China for imports could threaten India’s drug security: Export council DG

Udaya Bhaskar, Director-General of Pharmexcil, says India’s over-dependence on China for its bulk drugs requirement led to fall in exports in February and March.

Face scan, open doors, zig-zag seating, doctor-on-call: Pharma firms redefine Covid workplace

The pharmaceutical industry has functioned throughout the lockdown and as such is leading the way in creating a safe workplace amid Covid-19 pandemic. 

Why India saw only 4 pharma products launched in April, its lowest count ever

The pharma industry has seen a fall of about 99% in new product launches since April 2019, when 349 products were launched.

On Camera

YourTurn

PM Modi at the MSME Idea Hackathon, 2022. | Praveen Jain | ThePrint

BJP, Modi’s ‘total politics’ stems from insecurity. They still don’t rule the power elite

Yogendra Yadav is wrong. BJP might have a hegemonic position in politics and economy, but it's not the same in moral and intellectual spaces.
The Reserve Bank of India logo | Photo: Suraj Singh Bisht | ThePrint

RBI intervenes with multi-pronged strategy in battle against rupee fall

The Reserve Bank’s challenges include crashes in forward dollar premiums to rising open interest in futures that adds to pressure on the currency.

Defence

The maiden flight of the Autonomous Flying Wing Technology Demonstrator | Photo: DRDO

‘Major milestone’: India conducts maiden flight of unmanned aircraft demonstrator

DRDO calls flight a significant step towards self-reliance in defence technologies; Defence Minister Rajnath Singh lauds achievement, says ‘it paves way for Aatmanirbhar Bharat in critical military systems’.

With Agnipath, Modi govt’s shock & awe doctrine may have misfired a vital reform, yet again

Modi govt's biggest flaw has been its disinclination to accept limitations of electoral majorities. This ruined land acquisition and farm reform, stalled labour codes.
×